Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 A resolution.

In the pharmaceutical industry, knowledge of the three-dimensional structure of a specific target facilitates the drug-discovery process. Despite possessing favoured analytical properties such as high purity and monodispersion in light scattering, some proteins are not capable of forming crystals suitable for X-ray analysis. Cyclophilin D, an isoform of cyclophilin that is expressed in the mitochondria, was selected as a drug target for the treatment of cardiac disorders. As the wild-type enzyme defied all attempts at crystallization, protein engineering on the enzyme surface was performed. The K133I mutant gave crystals that diffracted to 1.7 A resolution using in-house X-ray facilities and were suitable for soaking experiments. The crystals were very robust and diffraction was maintained after soaking in 25% DMSO solution: excellent conditions for the rapid analysis of complex structures including crystallographic fragment screening.

[1]  Z. Derewenda,et al.  The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. , 2004, Structure.

[2]  Paul R. Gerber,et al.  Peptide mechanics: A force field for peptides and proteins working with entire residues as smallest units , 1992 .

[3]  G. Kroemer,et al.  Insights into the Mitochondrial Signaling Pathway: What Lessons for Chemotherapy? , 2003, Journal of Clinical Immunology.

[4]  M. Eftink,et al.  Fluorescence methods for studying kinetics of protein-folding reactions. , 1997, Methods in enzymology.

[5]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[6]  Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. , 1991 .

[7]  A. Galat,et al.  Peptidylproline cis-trans-isomerases: immunophilins. , 1993, European journal of biochemistry.

[8]  G. Roberts,et al.  Correction for light absorption in fluorescence studies of protein-ligand interactions. , 1983, Analytical biochemistry.

[9]  P. Taylor,et al.  X-Ray Structures and Analysis of 11 Cyclosporin Derivatives Complexed with Cyclophilin A. , 1998 .

[10]  Zygmunt S Derewenda,et al.  Rational protein crystallization by mutational surface engineering. , 2004, Structure.

[11]  J. E. Villafranca,et al.  Studies on engineering crystallizability by mutation of surface residues of human thymidylate synthase , 1992 .

[12]  J. Kofron,et al.  Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. , 1991, Biochemistry.

[13]  M. Mclaughlin,et al.  The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms. , 1991, The Journal of biological chemistry.

[14]  W. V. Shaw,et al.  Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts , 1991, Nature.